JP2012514983A5 - - Google Patents

Download PDF

Info

Publication number
JP2012514983A5
JP2012514983A5 JP2011545540A JP2011545540A JP2012514983A5 JP 2012514983 A5 JP2012514983 A5 JP 2012514983A5 JP 2011545540 A JP2011545540 A JP 2011545540A JP 2011545540 A JP2011545540 A JP 2011545540A JP 2012514983 A5 JP2012514983 A5 JP 2012514983A5
Authority
JP
Japan
Prior art keywords
cell
composition
cells
pluripotent
cultured
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011545540A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012514983A (ja
JP5711149B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/020884 external-priority patent/WO2010083203A2/en
Publication of JP2012514983A publication Critical patent/JP2012514983A/ja
Publication of JP2012514983A5 publication Critical patent/JP2012514983A5/ja
Application granted granted Critical
Publication of JP5711149B2 publication Critical patent/JP5711149B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011545540A 2009-01-13 2010-01-13 非胚性幹細胞およびその使用 Expired - Fee Related JP5711149B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14420609P 2009-01-13 2009-01-13
US61/144,206 2009-01-13
PCT/US2010/020884 WO2010083203A2 (en) 2009-01-13 2010-01-13 Non-embryonic stem cells and uses thereof

Publications (3)

Publication Number Publication Date
JP2012514983A JP2012514983A (ja) 2012-07-05
JP2012514983A5 true JP2012514983A5 (https=) 2012-10-18
JP5711149B2 JP5711149B2 (ja) 2015-04-30

Family

ID=42337124

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011545540A Expired - Fee Related JP5711149B2 (ja) 2009-01-13 2010-01-13 非胚性幹細胞およびその使用

Country Status (6)

Country Link
US (1) US8394630B2 (https=)
EP (1) EP2387609B1 (https=)
JP (1) JP5711149B2 (https=)
CN (1) CN102333863A (https=)
ES (1) ES2675553T3 (https=)
WO (1) WO2010083203A2 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8563307B2 (en) * 2009-02-24 2013-10-22 James Wang Treatment of immunosuppression-related disorders
US8679474B2 (en) 2010-08-04 2014-03-25 StemBios Technologies, Inc. Somatic stem cells
WO2012174225A2 (en) 2011-06-14 2012-12-20 The University Of North Carolina At Chapel Hill Isolation, expansion and use of autologous pluripotent stem cells
TWI571513B (zh) * 2011-09-28 2017-02-21 幹細胞生物科技股份有限公司 體幹細胞及其製備方法
WO2014089268A2 (en) 2012-12-06 2014-06-12 StemBios Technologies, Inc. Lgr5+ somatic stem cells
EP2746769A1 (en) 2012-12-21 2014-06-25 Stembios Technologies, Inc. Method for evaluating effect of action on subject based on stem celldynamics
WO2014143383A1 (en) 2013-03-13 2014-09-18 Agilent Technologies, Inc. Transposome tethered to a gene delivery vehicle
JP2018501189A (ja) * 2014-11-19 2018-01-18 ステムバイオス テクノロジーズ,インコーポレイテッド 骨欠損を治療するための体性幹細胞
WO2017070525A1 (en) 2015-10-22 2017-04-27 University Of Massachusetts Methods and compositions for treating metabolic imbalance in neurodegenerative disease
US11413356B2 (en) 2016-04-15 2022-08-16 University Of Massachusetts Methods and compositions for treating metabolic imbalance
TW202328432A (zh) * 2021-08-26 2023-07-16 清華大學 誘導全能性幹細胞及其製備方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US6916654B1 (en) 1992-06-29 2005-07-12 Oklahoma Medical Research Foundation Universal donor cells
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5591625A (en) 1993-11-24 1997-01-07 Case Western Reserve University Transduced mesenchymal stem cells
US5908779A (en) 1993-12-01 1999-06-01 University Of Connecticut Targeted RNA degradation using nuclear antisense RNA
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5837533A (en) 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
AU6869198A (en) 1997-03-25 1998-10-20 Morphogenesis, Inc. Universal stem cells
US20030161817A1 (en) * 2001-03-28 2003-08-28 Young Henry E. Pluripotent embryonic-like stem cells, compositions, methods and uses thereof
WO2002045506A1 (en) * 2000-10-26 2002-06-13 University Of Florida Drug screening system
EP1379624A2 (en) 2000-11-27 2004-01-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Transfection of human embryonic stem cells
JP3977136B2 (ja) * 2001-05-22 2007-09-19 キヤノン株式会社 コイルユニット
US7422736B2 (en) 2002-07-26 2008-09-09 Food Industry Research And Development Institute Somatic pluripotent cells
WO2004042023A2 (en) 2002-11-01 2004-05-21 Five Prime Therapeutics, Inc. Stem cell libraries
EP1789540B9 (en) * 2004-09-03 2012-02-22 Moraga Biotechnology Inc. Non-embryonic totipotent blastomer-like stem cells and methods therefor
EP2410044B1 (en) 2004-12-29 2022-06-22 Hadasit Medical Research Services And Development Ltd. Stem cells culture systems
WO2007026353A2 (en) * 2005-08-29 2007-03-08 Technion Research & Development Foundation Ltd. Media for culturing stem cells
WO2007082177A2 (en) * 2006-01-06 2007-07-19 Mount Sinai School Of Medicine Of New York University Myeloid suppressor cells, methods for preparing them, and methods for using them for treating autoimmunity
EP1991666A4 (en) * 2006-02-27 2009-06-10 Moraga Biotech Corp NON-EMBRYONIC TOTIPOTENT STEM CELLS OF BLASTOMERIC TYPE AND METHODS

Similar Documents

Publication Publication Date Title
JP2012514983A5 (https=)
Zeng et al. Single-cell RNA sequencing resolves spatiotemporal development of pre-thymic lymphoid progenitors and thymus organogenesis in human embryos
Zwijnenburg et al. Graded expression of the chemokine receptor CX3CR1 marks differentiation states of human and murine T cells and enables cross-species interpretation
Wu et al. Immune tolerance of embryo implantation and pregnancy: the role of human decidual stromal cell-and embryonic-derived extracellular vesicles
Tempest et al. Endometrial stem cell markers: current concepts and unresolved questions
Dey et al. Dissecting the molecular relationship among various cardiogenic progenitor cells
Zou et al. CD4+ T cell immunity is dependent on an intrinsic stem-like program
Papadimitropoulos et al. Expansion of human mesenchymal stromal cells from fresh bone marrow in a 3D scaffold-based system under direct perfusion
Abplanalp et al. Single-cell technologies to decipher cardiovascular diseases
Chihara et al. Differentiation and characterization of Tr1 cells
Biel et al. Vascular smooth muscle cells from hypertensive patient-derived induced pluripotent stem cells to advance hypertension pharmacogenomics
Liu et al. Patient‐Derived Tumor Organoids Combined with Function‐Associated ScRNA‐Seq for Dissecting the Local Immune Response of Lung Cancer
JP2012516686A5 (https=)
Liao et al. Stereo-cell: Spatial enhanced-resolution single-cell sequencing with high-density DNA nanoball-patterned arrays
Huang et al. Development and evaluation of IL‐6 overexpressing mesenchymal stem cells (MSCs)
Ragni et al. Secreted factors and extracellular vesicles account for the immunomodulatory and tissue regenerative properties of bone-marrow-derived mesenchymal stromal cells for osteoarthritis
Jiang et al. Single-cell RNA-sequencing reveals interactions between endometrial stromal cells, epithelial cells, and lymphocytes during mouse embryo implantation
Fong et al. A serum-and feeder-free system to generate CD4 and regulatory T cells from human iPSCs
Al Madhoun et al. Comparative proteomic analysis identifies EphA2 as a specific cell surface marker for Wharton’s jelly-derived mesenchymal stem cells
Watzling et al. Three-dimensional breast cancer model to investigate CCL5/CCR1 expression mediated by direct contact between breast cancer cells and adipose-derived stromal cells or adipocytes
Primak et al. Novel immortalized human multipotent mesenchymal stromal cell line for studying hormonal signaling
Na et al. The IL-6 signaling pathway contributes critically to the immunomodulatory mechanism of human decidua-derived mesenchymal stromal cells
Blinova et al. Modulation of suppressive activity and proliferation of human regulatory T cells by splice-switching oligonucleotides targeting FoxP3 pre-mRNA
Georgi et al. MicroRNA levels as prognostic markers for the differentiation potential of human mesenchymal stromal cell donors
Zhdanov et al. Induction of FoxP3 Pre-mRNA alternative splicing to enhance the suppressive activity of regulatory T cells from amyotrophic lateral sclerosis patients